Ming-Qing Du Selected Research

Ming-Qing Du Research Topics

Disease

25	Lymphoma (Lymphomas) 10/2021 - 01/2002
24	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2022 - 01/2002
10	Neoplasms (Cancer) 01/2019 - 05/2004
7	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2019 - 09/2006
5	B-Cell Lymphoma (Lymphoma, B Cell) 10/2021 - 01/2016
4	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 05/2013 - 01/2003
3	Bacterial Infections (Bacterial Infection) 02/2012 - 02/2002
3	Genetic Translocation (Chromosomal Translocation) 05/2008 - 02/2005
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2020 - 09/2009
2	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2019 - 01/2003
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019 - 03/2008
2	Necrosis 05/2012 - 09/2006
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2004 - 06/2003
1	Hairy Cell Leukemia 01/2019
1	Melanoma (Melanoma, Malignant) 05/2013
1	Glaucoma 05/2013
1	Uveitis 05/2013
1	Exanthema (Rash) 02/2012
1	Multiple Sclerosis 03/2011
1	Primary Effusion Lymphoma 10/2010
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 03/2010
1	Breast Neoplasms (Breast Cancer) 12/2009
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2009
1	Myeloid Leukemia (Leukemia, Myelocytic) 11/2007
1	Infections 11/2007
1	Latent Infection 01/2006
1	Carcinogenesis 05/2005
1	Hyperplasia 11/2004
1	Multiple Myeloma 11/2004
1	Gastritis 08/2003
1	Sialadenitis 08/2003
1	Hashimoto Disease (Thyroiditis, Hashimoto) 08/2003
1	Lymphadenopathy 11/2002
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 04/2002
1	Castleman Disease (Castleman's Disease) 04/2002

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2005
5	Biological ProductsIBA 01/2019 - 01/2005
5	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 09/2006
4	AntigensIBA 01/2019 - 12/2002
4	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2017 - 06/2003
3	B-Cell CLL-Lymphoma 10 ProteinIBA 01/2009 - 01/2002
3	NF-kappa B (NF-kB)IBA 01/2009 - 05/2005
3	Anti-Bacterial Agents (Antibiotics)IBA 11/2007 - 05/2002
2	Immunoglobulins (Immunoglobulin)IBA 01/2019 - 11/2004
2	Bortezomib (Velcade)FDA Link 01/2019 - 10/2018
2	IgKIBA 01/2019 - 10/2011
2	Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 ProteinIBA 01/2015 - 05/2005
2	Toll-Like Receptors (Toll-Like Receptor)IBA 05/2012 - 04/2012
2	MicroRNAs (MicroRNA)IBA 01/2012 - 12/2009
2	Formaldehyde (Formol)FDA Link 06/2011 - 09/2006
2	ParaffinIBA 06/2011 - 07/2007
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2009 - 01/2006
2	Biomarkers (Surrogate Marker)IBA 03/2008 - 10/2007
2	Interleukin-6 (Interleukin 6)IBA 01/2006 - 04/2002
2	Oxygen (Dioxygen)IBA 08/2003 - 02/2002
1	BuffersIBA 10/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020
1	VemurafenibIBA 01/2019
1	Complementarity Determining Regions (Complementarity Determining Region)IBA 01/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	Proteasome InhibitorsIBA 10/2018
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2018
1	CarbohydratesIBA 01/2017
1	TNF Receptor-Associated Factor 3IBA 01/2017
1	CD40 Ligand (CD40L)IBA 01/2016
1	LigandsIBA 01/2016
1	Mitochondrial DNA (mtDNA)IBA 10/2014
1	16S Ribosomal RNAIBA 03/2014
1	Protons (Proton)IBA 05/2013
1	StathminIBA 05/2013
1	AntibodiesIBA 05/2013
1	Monoclonal AntibodiesIBA 05/2012
1	Oncogene Proteins (Oncogene Protein)IBA 01/2011
1	Phosphotransferases (Kinase)IBA 01/2011
1	Arginine (L-Arginine)FDA Link 01/2011
1	Protein Sorting Signals (Signal Peptide)IBA 03/2010
1	NucleotidesIBA 03/2010
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2009
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 11/2007
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 09/2006
1	TNF Receptor-Associated Factor 2 (TRAF2)IBA 04/2006
1	UbiquitinIBA 05/2005
1	Ligases (Synthetase)IBA 05/2005
1	Antigen Receptors (Antigen Receptor)IBA 02/2005
1	Immunoglobulin M (IgM)IBA 11/2004
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 11/2004
1	fludarabineIBA 05/2004
1	NucleosidesIBA 01/2004
1	Cladribine FDA LinkGeneric 01/2004
1	RNA (Ribonucleic Acid)IBA 01/2003
1	Immunoglobulin Variable RegionIBA 01/2003
1	AutoantigensIBA 02/2002
1	Free RadicalsIBA 02/2002
1	InterferonsIBA 01/2002

Therapy/Procedure

7	Therapeutics 01/2019 - 05/2002
5	Drug Therapy (Chemotherapy) 01/2019 - 01/2002
3	Radiotherapy 05/2013 - 01/2002
1	Aftercare (After-Treatment) 02/2012
1	Gastrectomy 04/2003
1	Injections 01/2002